Better Tests for Liver Toxicity Would Mean More Medicines — and Safer Medicines — for Patients
American Chemical Society (ACS)How many breakthrough new drugs never reach patients because tests in clinical trials suggested a high risk of liver damage when the drug actually was quite safe? That question underpins major international research efforts to modernize tests for drug-induced liver injury, mentioned here today at the 246th National Meeting & Exposition of the American Chemical Society, the world’s largest scientific society.